BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Fish and Richardson
Daiichi Sankyo
McKinsey
AstraZeneca
Fuji
Covington
Farmers Insurance
Queensland Health
Cantor Fitzgerald

Generated: January 17, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,079,262

« Back to Dashboard

Summary for Patent: 5,079,262
Title: Method of detection and treatment of malignant and non-malignant lesions utilizing 5-aminolevulinic acid
Abstract:A method of detecting and treating malignant and non-malignant tissue abnormalities and lesions of the skin, conjunctives, respiratory, digestive and vaginal mucosa; endometrium and urothelium in which 5-aminolevulinic acid is administered to the patient in an amount sufficient to induce synthesis of protoporphyrin IX in the leisons, followed by exposure of the treated lesion to a photoactivating light in the range 350-640 nm.
Inventor(s): Kennedy; James C. (Kingston, CA), Pottier; Roy H. (Kingston, CA), Reid; Robert L. (Kingston, CA)
Assignee: Queen's University at Kingston (Kingston, CA)
Application Number:07/386,414
Patent Claim Types:
see list of patent claims
Use; Delivery;

Drugs Protected by US Patent 5,079,262

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 5,079,262

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Spain 2236731 ➤ Subscribe
Japan 2731032 ➤ Subscribe
Japan H04500770 ➤ Subscribe
European Patent Office 1510225 ➤ Subscribe
European Patent Office 0831909 ➤ Subscribe
European Patent Office 0634929 ➤ Subscribe
Denmark 0831909 ➤ Subscribe
Germany 69634250 ➤ Subscribe
Australia 674310 ➤ Subscribe
Australia 3883293 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Teva
Harvard Business School
Chubb
Chinese Patent Office
US Army
Accenture
McKinsey
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot